Ftse Mib
34.676,17
1,15%
DAX
19.254,97
1,03%
S&P 500
5.728,80
0,41%
NASDAQ
18.239,92
0,80%
Bitcoin
69.553,51
0,10%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Abbott Laboratories (ABT) Abbott Laboratories (ABT) Notizie

Abbott Laboratories

ABT
118,88
5,51 (4,86%)
02 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/11/202411:57IHMARKETNEWSIndex Futures Rise on Jobs Report and Chevron, Exxon..
01/11/202411:55IHMARKETNEWSAmazon Up 6%, Atlassian Jumps 20%; Intel Posts Surprising..
31/10/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202415:08PRNCAUn nouveau rapport canadien montre qu'une attitude positive..
30/10/202414:50PRNCANew Canadian Report Shows Positivity Instead of Criticism is..
24/10/202415:00PRNUSAbbott Initiates New Clinical Trial to Improve Outcomes in..
23/10/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202422:08EDGAR2Form 144 - Report of proposed sale of securities
16/10/202413:37EDGAR2Form 8-K - Current report
16/10/202413:30PRNUSAbbott Reports Third-Quarter 2024 Results and Raises..
10/10/202415:00PRNUSAbbott Advances Pulsed Field Ablation Clinical Studies and..
01/10/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202420:00PRNUSAbbott and the Big Ten Conference Tackle U.S. Blood..
25/9/202415:00PRNUSAbbott Hosts Conference Call for Third-Quarter Earnings
19/9/202418:59PRNUSAbbott Declares 403rd Consecutive Quarterly Dividend
13/9/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202400:20EDGAR2Form 144 - Report of proposed sale of securities
05/9/202415:00PRNUSAbbott's Lingo™ Continuous Glucose Monitor for Health and..
05/9/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:04EDGAR2Form 144 - Report of proposed sale of securities
04/9/202415:00PRNUSAbbott Initiates Clinical Study to Evaluate the Use of Its..
27/8/202415:00PRNUSAbbott Expands its Pure Bliss™ Line of Infant Formulas to..
15/8/202420:18PRNCAAVEIR(MC) DR d'Abbott - Le premier système de stimulateur..
15/8/202419:44PRNCAAbbott's AVEIR™ DR - World's First Dual Chamber Leadless..
08/8/202415:00PRNCAQuebec Expands Public Reimbursement of Abbott's FreeStyle..
07/8/202414:00PRNUSAbbott Enters Global Partnership to Connect Its..
06/8/202415:00PRNUSCadrenal Therapeutics and Abbott Initiate Collaborative..
31/7/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/7/202412:24IHMARKETNEWSApple Delays AI Features, Abbott Shares Plunge 7% After..
19/7/202412:01IHMARKETNEWSMicrosoft Shares Drop 2% and CrowdStrike Plunges 21%..
18/7/202413:37EDGAR2Form 8-K - Current report
18/7/202413:30PRNUSAbbott Reports Second-Quarter 2024 Results and Raises..
18/7/202412:01IHMARKETNEWSNasdaq Tech Stocks Show Partial Recovery; Oil Prices Rise
09/7/202412:54IHMARKETNEWSBP Slashes Profit Forecast by $700 Million; Morgan Stanley..
27/6/202414:00PRNUSAbbott Hosts Conference Call for Second-Quarter Earnings
20/6/202414:05PRNUSAbbott Teams Up With the National Association of Community..
14/6/202418:01PRNUSAbbott Declares 402nd Consecutive Quarterly Dividend
10/6/202414:00PRNUSAbbott Receives U.S. FDA Clearance for Two New..
03/6/202415:00PRNUSCadrenal Therapeutics Highlights Presentation of New Trial..
30/5/202422:07EDGAR2Form SD - Specialized disclosure report
14/5/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:52EDGAR2Form 144 - Report of proposed sale of securities
08/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202400:59EDGAR2Form 144 - Report of proposed sale of securities
29/4/202415:00PRNUSAbbott's Breakthrough Dissolving Stent Receives FDA Approval..
17/4/202417:37IHMARKETNEWSAbbott Laboratories Reports Strong Q1 Sales Growth Amid..
Apertura: 119,98 Min: 117,09 Max: 119,98
Chiusura: 113,37

La tua Cronologia

NYSE
ABT
Abbott Laboratories
LSE
AAPI
Income Aapl
NASDAQ
MGX
Metagenomi
ASX
ABT
Abundant Produce
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network